Neuroprotectant Drug Shows Promise in Human Ischemic Stroke

被引：2

作者：

Munson, Troy ^{[1
]}

Amin-Hanjani, Sepideh ^{[1
]}

机构：

[1] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA

来源：

WORLD NEUROSURGERY | 2013年 / 79卷 / 3-4期

关键词：

D O I：

10.1016/j.wneu.2013.01.087

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：408 / 409

页数：2

共 3 条

[1] Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations [J].

Fisher, Marc ;

Feuerstein, Giora ;

Howells, David W. ;

Hurn, Patricia D. ;

Kent, Thomas A. ;

Savitz, Sean I. ;

Lo, Eng H. .

STROKE, 2009, 40 (06) :2244-2250

[2] Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial [J].

Hill, Michael D. ;

Martin, Renee H. ;

Mikulis, David ;

Wong, John H. ;

Silver, Frank L. ;

terBrugge, Karel G. ;

Milot, Genevieve ;

Clark, Wayne M. ;

MacDonald, R. Loch ;

Kelly, Michael E. ;

Boulton, Melford ;

Fleetwood, Ian ;

McDougall, Cameron ;

Gunnarsson, Thorsteinn ;

Chow, Michael ;

Lum, Cheemun ;

Dodd, Robert ;

Poublanc, Julien ;

Krings, Timo ;

Demchuk, Andrew M. ;

Goyal, Mayank ;

Anderson, Roberta ;

Bishop, Julie ;

Garman, David ;

Tymianski, Michael .

LANCET NEUROLOGY, 2012, 11 (11) :942-950

[3] Can Molecular and Cellular Neuroprotection Be Translated Into Therapies for Patients? Yes, but Not the Way We Tried It Before [J].

Tymianski, Michael .

STROKE, 2010, 41 (10) :S87-S90

← 1 →